Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Income Statement [Abstract]    
Revenue $ 512
Operating costs and expenses:    
Inventor royalties, contingent legal fees, litigation and licensing expenses 385
Research and development expenses (including non-cash share based compensation expenses of $3,635 and $4,166, respectively) 6,703 6,190
General and administrative expenses (including non-cash share based compensation expenses of $3,020 and $3,892, respectively) 7,172 7,073
Total operating costs and expenses 13,875 13,648
Loss from operations (13,875) (13,136)
Gain on disposal of property and equipment 6
Interest income 104 2
Net loss (13,771) (13,128)
Less: Net loss attributable to noncontrolling interest (176) (174)
Net loss attributable to common stockholders $ (13,595) $ (12,954)
Net loss per share:    
Basic and diluted $ (0.45) $ (0.45)
Weighted average common shares outstanding:    
Basic and diluted 30,374 28,579